WALTHAM, Mass., May 20 /PRNewswire-FirstCall/ -- Inverness
Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling
individuals to take charge of their health at home through the
merger of rapid diagnostics and health management, announced today
that it will attend the Jefferies 2010 Global Life Sciences
Conference being held June 8 through 11,
2010 at the Grand Hyatt, New York,
New York. Ron Zwanziger, Chief Executive Officer, and
Jon Russell, Vice President,
Finance, will attend. Mr. Zwanziger's presentation is scheduled for
Tuesday, June 8, 2010 at 9:30 a.m., and will be made available to the
public through a webcast accessible via
http://www.wsw.com/webcast/jeff46/ima/ as well as through the
company's website at http://www.invmed.com/investors.cfm. A
replay of the webcast will be available via the links above for
approximately 30 days from the date of the webcast. During
his presentation, Mr. Zwanziger may discuss and answer questions
concerning business and financial developments and trends.
His responses to questions, as well as other matters
discussed during the webcast, may contain or constitute information
that has not been disclosed previously.
By developing new capabilities in near-patient diagnosis,
monitoring and health management, Inverness Medical Innovations
enables individuals to take charge of improving their health and
quality of life. A global leader in rapid point-of-care
diagnostics, Inverness' products, as well as its new product
development efforts, focus on infectious disease, cardiology,
oncology, drugs of abuse and women's health. Inverness is
headquartered in Waltham,
Massachusetts.
SOURCE Inverness Medical Innovations, Inc.